483
James Alexander Corp.James Alexander Corp. – FDA 483, Feb 27, 2019
Record Details
An FDA inspection of James Alexander Corp in Blairstown, NJ, a drug contact manufacturer, revealed significant deficiencies in their quality control unit's written procedures. Specifically, the firm lacked approved procedures for handling deviations and change controls, with existing procedures remaining in draft status for approximately one year. This indicates a critical lapse in maintaining a robust quality system.
- Person
View Company Profile
ID · 474497fc-da49-4b7c-ad2e-afce6dc5de89
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.